BrightSpring Health Services (BTSG) recently hosted an investor day where management outlined new long term organic EBITDA growth targets through 2028 and highlighted acceleration in key business segments and AI driven efficiency efforts.
See our latest analysis for BrightSpring Health Services.
At a share price of US$45.33, BrightSpring has seen a 7 day share price return of 5.17% and a 90 day share price return of 20.78%, while the 1 year total shareholder return of 165.24% reflects recent investor focus on the investor day guidance and the upcoming first quarter 2026 results.
If the investor day story has you thinking more broadly about healthcare and AI, it could be worth scanning 31 healthcare AI stocks
With BrightSpring trading at US$45.33, close to its recent highs and with brokers expressing clear optimism, the key question is whether today’s valuation still leaves upside or if the market is already pricing in future growth.
Most Popular Narrative: 11.1% Undervalued
BrightSpring’s widely followed narrative points to a fair value of $51.00 versus the last close at $45.33. This frames the current share price as below that modeled level and ties the story to acquisition integration and long term earnings expansion.
The company's ability to routinely execute low-multiple, accretive acquisitions and leverage scale (as seen in recent deals/turnarounds like Haven Hospice) helps to diversify revenue streams and maintain double-digit earnings growth, even as industry consolidation intensifies.
Read the complete narrative. Read the complete narrative.
Want to see what earnings profile and margin shift are baked into that $51.00 figure? The narrative leans on rising profitability, stronger cash generation and a future earnings multiple that assumes meaningful execution.
Result: Fair Value of $51.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this story can be knocked off course if labor costs stay elevated or if changes to Medicare and Medicaid reimbursement pressure earnings and cash generation.
Find out about the key risks to this BrightSpring Health Services narrative.
Another Way To Look At Valuation
The SWS fair ratio points to a very different message. BrightSpring trades on a P/E of 87x, compared with about 22.6x for the wider US Healthcare group and a fair ratio of 32.4x that the market could move toward, which lifts valuation risk if sentiment cools.
To see how those earnings multiples stack up in more detail, it is worth checking the full valuation breakdown See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals on valuation and sentiment, this is a moment to move quickly: review the data for yourself and weigh both sides of the story with 3 key rewards and 1 important warning sign
Looking for more investment ideas?
If BrightSpring has sharpened your interest, do not stop here. Widen your watchlist with a few focused stock ideas built from clear financial filters and fundamentals.
- Target potential mispricing by reviewing companies that screen as 59 high quality undervalued stocks based on earnings quality and balance sheet support, so you are not relying only on headline stories.
- Prioritise resilience by checking out 72 resilient stocks with low risk scores that pair lower risk scores with business profiles that may appeal if you want fewer surprises.
- Get ahead of the crowd by scanning a screener containing 23 high quality undiscovered gems that focuses on quality fundamentals before they catch wider attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com